ID   K2C8_RAT                Reviewed;         483 AA.
AC   Q10758; Q5WPB3;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-OCT-2024, entry version 181.
DE   RecName: Full=Keratin, type II cytoskeletal 8;
DE   AltName: Full=Cytokeratin endo A;
DE   AltName: Full=Cytokeratin-8;
DE            Short=CK-8;
DE   AltName: Full=Keratin-8;
DE            Short=K8;
DE   AltName: Full=Type-II keratin Kb8;
GN   Name=Krt8; Synonyms=Krt2-8;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Prostate;
RX   PubMed=1370816; DOI=10.1016/s0021-9258(18)45878-4;
RA   Hsieh J.-T., Zhau H.E., Wang X.-H., Liew C.-C., Chung L.W.K.;
RT   "Regulation of basal and luminal cell-specific cytokeratin expression in
RT   rat accessory sex organs. Evidence for a new class of androgen-repressed
RT   genes and insight into their pairwise control.";
RL   J. Biol. Chem. 267:2303-2310(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Prostate;
RX   PubMed=7525090;
RA   Wang X., Hsieh J.-T., Zhau H.E.;
RT   "Cloning and characterization of a specific cytokeratin-8 cDNA from rat
RT   prostatic epithelium.";
RL   Zhongguo Yi Xue Ke Xue Yuan Xue Bao 16:1-7(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH DMD, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Heart muscle;
RX   PubMed=15247274; DOI=10.1074/jbc.m400128200;
RA   Ursitti J.A., Lee P.C., Resneck W.G., McNally M.M., Bowman A.L.,
RA   O'Neill A., Stone M.R., Bloch R.J.;
RT   "Cloning and characterization of cytokeratins 8 and 19 in adult rat
RT   striated muscle. Interaction with the dystrophin glycoprotein complex.";
RL   J. Biol. Chem. 279:41830-41838(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta, and Thymus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 9-18; 24-75 AND 415-452, AND PHOSPHORYLATION AT SER-9;
RP   SER-13; SER-24; SER-34; SER-37; SER-43; SER-51; SER-417; SER-424 AND
RP   SER-426.
RC   TISSUE=Liver;
RX   PubMed=8660345; DOI=10.1006/bbrc.1996.0546;
RA   Ando S., Tokui T., Yano T., Inagaki M.;
RT   "Keratin 8 phosphorylation in vitro by cAMP-dependent protein kinase occurs
RT   within the amino- and carboxyl-terminal end domains.";
RL   Biochem. Biophys. Res. Commun. 221:67-71(1996).
RN   [6]
RP   PROTEIN SEQUENCE OF 265-273, AND SUBCELLULAR LOCATION.
RC   TISSUE=Liver;
RX   PubMed=16128803; DOI=10.1111/j.1742-4658.2005.04847.x;
RA   Segawa M., Niino K., Mineki R., Kaga N., Murayama K., Sugimoto K.,
RA   Watanabe Y., Furukawa K., Horigome T.;
RT   "Proteome analysis of a rat liver nuclear insoluble protein fraction and
RT   localization of a novel protein, ISP36, to compartments in the
RT   interchromatin space.";
RL   FEBS J. 272:4327-4338(2005).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16396499; DOI=10.1021/pr0503073;
RA   Moser K., White F.M.;
RT   "Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-
RT   MS/MS.";
RL   J. Proteome Res. 5:98-104(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; SER-24; THR-26; SER-27;
RP   SER-43; SER-44; SER-47; SER-51; SER-253; SER-258; SER-432; SER-475; SER-478
RP   AND SER-482, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Together with KRT19, helps to link the contractile apparatus
CC       to dystrophin at the costameres of striated muscle.
CC       {ECO:0000269|PubMed:15247274}.
CC   -!- SUBUNIT: Heterotetramer of two type I and two type II keratins (By
CC       similarity). Forms a heterodimer with KRT18 (By similarity). Associates
CC       with KRT20 (By similarity). Interacts with PNN (By similarity). When
CC       associated with KRT19, interacts with DMD (PubMed:15247274). Interacts
CC       with TCHP (By similarity). Interacts with APEX1 (By similarity).
CC       Interacts with GPER1 (By similarity). Interacts with EPPK1 (By
CC       similarity). Interacts with PKP1 and PKP2 (By similarity).
CC       {ECO:0000250|UniProtKB:P05787, ECO:0000250|UniProtKB:P11679,
CC       ECO:0000269|PubMed:15247274}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16128803}. Nucleus,
CC       nucleoplasm {ECO:0000269|PubMed:16128803}. Nucleus matrix
CC       {ECO:0000269|PubMed:16128803}.
CC   -!- TISSUE SPECIFICITY: Expressed in cardiac and striated muscle. Expressed
CC       at Z-lines within the muscle fibers and at Z-line and M-line domains at
CC       costameres at the sarcolemmal membrane (at protein level). Observed in
CC       coagulating gland, bladder, salivary gland, kidney, spleen, thymus,
CC       lung and heart. Also observed in ventral prostate, seminal vesicle and
CC       liver where expression increases following castration.
CC       {ECO:0000269|PubMed:1370816, ECO:0000269|PubMed:15247274}.
CC   -!- PTM: O-glycosylated. O-GlcNAcylation at multiple sites increases
CC       solubility, and decreases stability by inducing proteasomal degradation
CC       (By similarity). {ECO:0000250}.
CC   -!- PTM: O-glycosylated (O-GlcNAcylated), in a cell cycle-dependent manner.
CC       {ECO:0000250}.
CC   -!- MISCELLANEOUS: There are two types of cytoskeletal and microfibrillar
CC       keratin: I (acidic; 40-55 kDa) and II (neutral to basic; 56-70 kDa).
CC   -!- SIMILARITY: Belongs to the intermediate filament family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01188}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA19668.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M63482; AAA19667.1; -; mRNA.
DR   EMBL; M63482; AAA19668.1; ALT_INIT; mRNA.
DR   EMBL; S76054; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AY464139; AAR36875.1; -; mRNA.
DR   EMBL; BC091106; AAH91106.1; -; mRNA.
DR   EMBL; BC097497; AAH97497.1; -; mRNA.
DR   RefSeq; NP_955402.1; NM_199370.1.
DR   AlphaFoldDB; Q10758; -.
DR   SMR; Q10758; -.
DR   BioGRID; 247655; 3.
DR   IntAct; Q10758; 8.
DR   MINT; Q10758; -.
DR   STRING; 10116.ENSRNOP00000029068; -.
DR   GlyGen; Q10758; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q10758; -.
DR   PhosphoSitePlus; Q10758; -.
DR   jPOST; Q10758; -.
DR   PaxDb; 10116-ENSRNOP00000029068; -.
DR   Ensembl; ENSRNOT00000038480.5; ENSRNOP00000029068.3; ENSRNOG00000009779.6.
DR   Ensembl; ENSRNOT00055045792; ENSRNOP00055037538; ENSRNOG00055026530.
DR   Ensembl; ENSRNOT00060024083; ENSRNOP00060019201; ENSRNOG00060014071.
DR   Ensembl; ENSRNOT00065033542; ENSRNOP00065026848; ENSRNOG00065019903.
DR   GeneID; 25626; -.
DR   KEGG; rno:25626; -.
DR   UCSC; RGD:2984; rat.
DR   AGR; RGD:2984; -.
DR   CTD; 3856; -.
DR   RGD; 2984; Krt8.
DR   eggNOG; ENOG502QURK; Eukaryota.
DR   GeneTree; ENSGT00940000153339; -.
DR   HOGENOM; CLU_012560_5_4_1; -.
DR   InParanoid; Q10758; -.
DR   OMA; XRASLEA; -.
DR   OrthoDB; 4640531at2759; -.
DR   PhylomeDB; Q10758; -.
DR   TreeFam; TF317854; -.
DR   Reactome; R-RNO-6805567; Keratinization.
DR   Reactome; R-RNO-6809371; Formation of the cornified envelope.
DR   PRO; PR:Q10758; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000009779; Expressed in jejunum and 17 other cell types or tissues.
DR   GO; GO:0016327; C:apicolateral plasma membrane; ISO:RGD.
DR   GO; GO:0071944; C:cell periphery; ISO:RGD.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0043034; C:costamere; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0016010; C:dystrophin-associated glycoprotein complex; IDA:UniProtKB.
DR   GO; GO:0005882; C:intermediate filament; ISO:RGD.
DR   GO; GO:0045095; C:keratin filament; IDA:RGD.
DR   GO; GO:0016363; C:nuclear matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0042383; C:sarcolemma; IDA:UniProtKB.
DR   GO; GO:0030018; C:Z disc; IDA:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:RGD.
DR   GO; GO:0060706; P:cell differentiation involved in embryonic placenta development; ISO:RGD.
DR   GO; GO:0097191; P:extrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0097284; P:hepatocyte apoptotic process; ISO:RGD.
DR   GO; GO:0051599; P:response to hydrostatic pressure; IDA:RGD.
DR   GO; GO:0051707; P:response to other organism; ISO:RGD.
DR   GO; GO:0045214; P:sarcomere organization; IDA:UniProtKB.
DR   GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; ISO:RGD.
DR   Gene3D; 1.20.5.170; -; 1.
DR   Gene3D; 1.20.5.500; Single helix bin; 1.
DR   Gene3D; 1.20.5.1160; Vasodilator-stimulated phosphoprotein; 1.
DR   InterPro; IPR018039; IF_conserved.
DR   InterPro; IPR039008; IF_rod_dom.
DR   InterPro; IPR032444; Keratin_2_head.
DR   InterPro; IPR003054; Keratin_II.
DR   PANTHER; PTHR45616; GATA-TYPE DOMAIN-CONTAINING PROTEIN; 1.
DR   PANTHER; PTHR45616:SF26; KERATIN, TYPE II CYTOSKELETAL 8; 1.
DR   Pfam; PF00038; Filament; 1.
DR   Pfam; PF16208; Keratin_2_head; 1.
DR   PRINTS; PR01276; TYPE2KERATIN.
DR   SMART; SM01391; Filament; 1.
DR   SUPFAM; SSF64593; Intermediate filament protein, coiled coil region; 3.
DR   PROSITE; PS00226; IF_ROD_1; 1.
DR   PROSITE; PS51842; IF_ROD_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Coiled coil; Cytoplasm; Direct protein sequencing;
KW   Glycoprotein; Intermediate filament; Isopeptide bond; Keratin; Methylation;
KW   Nucleus; Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN           1..483
FT                   /note="Keratin, type II cytoskeletal 8"
FT                   /id="PRO_0000063742"
FT   DOMAIN          91..402
FT                   /note="IF rod"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01188"
FT   REGION          1..90
FT                   /note="Head"
FT   REGION          1..43
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          91..126
FT                   /note="Coil 1A"
FT   REGION          127..143
FT                   /note="Linker 1"
FT   REGION          144..235
FT                   /note="Coil 1B"
FT   REGION          236..259
FT                   /note="Linker 12"
FT   REGION          260..398
FT                   /note="Coil 2"
FT   REGION          261..382
FT                   /note="Necessary for interaction with PNN"
FT                   /evidence="ECO:0000250"
FT   REGION          399..483
FT                   /note="Tail"
FT   SITE            342
FT                   /note="Stutter"
FT   MOD_RES         9
FT                   /note="Phosphoserine; by PKC/PRKCE"
FT                   /evidence="ECO:0000305|PubMed:8660345"
FT   MOD_RES         13
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8660345"
FT   MOD_RES         15
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   MOD_RES         21
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         22
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   MOD_RES         23
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   MOD_RES         24
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         24
FT                   /note="Phosphoserine; by PKC/PRKCE"
FT                   /evidence="ECO:0000305|PubMed:8660345,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         26
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         27
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         32
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   MOD_RES         34
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8660345"
FT   MOD_RES         37
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8660345"
FT   MOD_RES         39
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   MOD_RES         40
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   MOD_RES         43
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8660345,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         44
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         47
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         49
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   MOD_RES         49
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   MOD_RES         51
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8660345,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         101
FT                   /note="N6-malonyllysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         207
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   MOD_RES         253
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         258
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         274
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   MOD_RES         295
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   MOD_RES         325
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   MOD_RES         400
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   MOD_RES         404
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   MOD_RES         410
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   MOD_RES         417
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8660345"
FT   MOD_RES         424
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8660345"
FT   MOD_RES         426
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8660345"
FT   MOD_RES         432
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         475
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         477
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   MOD_RES         478
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         482
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CROSSLNK        11
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   CROSSLNK        122
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   CROSSLNK        130
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   CROSSLNK        197
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   CROSSLNK        197
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   CROSSLNK        285
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   CROSSLNK        295
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   CROSSLNK        304
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   CROSSLNK        325
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   CROSSLNK        393
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   CROSSLNK        472
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
FT   CROSSLNK        472
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P05787"
SQ   SEQUENCE   483 AA;  54019 MW;  F52521FFFD972C2A CRC64;
     MSVRVTQKSY KMSTSGPRAF SSRSFTSGPG ARISSSSFSR VGSSSSSFRG SLGGFGGAGV
     GGITAVTVNQ SLLNPLKLEV DPNIQAVRTQ EKEQIKTLNN KFASFIDKVR FLEQQNKMLE
     TKWSLLQQQK TSRSNMDNMF ESYINNLRRQ LEALGQEKLK LEVELGNMQG LVEDFKNKYE
     DEINKRTEME NEFVLIKKDV DEAYMNKVEL ESRLEGLTDE INFLRQIHEE EIRELQSQIS
     DTSVVLSMDN SRSLDMDSII AEVRAQYEEI ANRSRAEAET MYQIKYEELQ TLAGKHGDDL
     RRSKTEISEM NRNISRLQAE IDALKGQRAT LEAAIADAEQ RGELAVKDAN AKLEDLKNAL
     QKAKQDMARQ LREYQELMNV KLALDIEIAT YRKLLEGEES RLESGMQNMS IHTKTTSGYA
     GGLSSSYGGL TSPGFSYGMS SFQPGFGSVG GSSTYSRTKA VVVKKIETRD GKLVSESSDI
     MSK
//
